Trials / Completed
CompletedNCT01552811
Studies of Pancreatic Islet Mass by Positron Emission Tomography (PET)
Open Study to Investigate Pancreatic Islet Mass by Positron Emission Tomography Using the Tracer [11C]5-hydroxytryptophane
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Uppsala University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study investigates the hypothesis that differences in beta-cell mass in patients with diabetes and healthy individuals can be monitored by the positron emission tomography (PET) tracer \[11C\]5-hydroxytryptophane.
Conditions
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-03-01
- Completion
- 2013-03-01
- First posted
- 2012-03-13
- Last updated
- 2014-02-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01552811. Inclusion in this directory is not an endorsement.